enGene Therapeutics Inc. (ENGN): SCHEDULE 13G/A filed May 14, 2026

Form type

SCHEDULE 13G/A

Filing date

May 14, 2026

Accession number

0001373604-26-000042

Filer

enGene Therapeutics Inc. (CIK 1980845)